1. First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial. Issue 12 (1st December 2022) Authors: Braulke, Friederike; Zettl, Florian; Ziepert, Marita; Viardot, Andreas; Kahl, Christoph; Prange-Krex, Gabriele; Korfel, Agnieszka; Dreyling, Martin; Bott, Alexander; Wedding, Ulrich; Reichert, Dietmar; de Wit, Maike; Hartmann, Frank; Poeschel, Viola; Schmitz, Norbert; Witzens-Harig, Mathias; Klap... Journal: HemaSphere Issue: Volume 6:Issue 12(2022) Page Start: e808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group. Issue 7 (23rd July 2021) Authors: Hirt, Carsten; Hoster, Eva; Unterhalt, Michael; Hänel, Mathias; Prange-Krex, Gabriele; Forstpointner, Roswitha; Florschütz, Axel; Graeven, Ullrich; Frickhofen, Norbert; Wulf, Gerald; Lengfelder, Eva; Lerchenmüller, Christian; Schlag, Rudolf; Dierlamm, Judith; Fischer von Weikersthal, Ludwig; Ahme... Journal: HemaSphere Issue: Volume 5:Issue 7(2021) Page Start: e600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗